Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Larson

Showing results (1331-1340 of 1,352) with videos related to

Pageof 136
Sort By:
Cancer Discovery|November 23, 2022
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin LymphomaSarah M Larson, Christopher M Walthers, Brenda Ji, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 22, 2023
Efficacy of HER2-Targeted Intraperitoneal <sup>225</sup>Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal CarcinomatosisSebastian K Chung, Daniela Burnes Vargas, Christopher S Chandler, et al.
Cell Reports. Medicine|November 29, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Yu Jeong Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2015
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate CancerNeeta Pandit-Taskar, Joseph A O'Donoghue, Jeremy C Durack, et al.
Nature Chemical Biology|September 28, 2011
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90Kamalika Moulick, James H Ahn, Hongliang Zong, et al.
Cancer Chemotherapy and Pharmacology|January 26, 2017
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)Ghassan K Abou-Alfa, Chia-Jui Yen, Chih-Hung Hsu, et al.
JCO Precision Oncology|October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate CancerDavid R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Cancer Cell|November 1, 2019
Paradigms for Precision Medicine in Epichaperome Cancer TherapyNagavarakishore Pillarsetty, Komal Jhaveri, Tony Taldone, et al.
Hepatology (Baltimore, Md.)|February 15, 2012
Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantationDeborah L Diamond, Alexei L Krasnoselsky, Kristin E Burnum, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2018
Reproducibility and Repeatability of Semiquantitative <sup>18</sup>F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter StudyHebert Alberto Vargas, Gem M Kramer, Andrew M Scott, et al.
Pageof 136

Showing results (1331-1340 of 1,352) with videos related to

Sort By:
Pageof 136
Cancer Discovery|November 23, 2022
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin LymphomaSarah M Larson, Christopher M Walthers, Brenda Ji, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 22, 2023
Efficacy of HER2-Targeted Intraperitoneal <sup>225</sup>Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal CarcinomatosisSebastian K Chung, Daniela Burnes Vargas, Christopher S Chandler, et al.
Cell Reports. Medicine|November 29, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Yu Jeong Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2015
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate CancerNeeta Pandit-Taskar, Joseph A O'Donoghue, Jeremy C Durack, et al.
Nature Chemical Biology|September 28, 2011
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90Kamalika Moulick, James H Ahn, Hongliang Zong, et al.
Cancer Chemotherapy and Pharmacology|January 26, 2017
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)Ghassan K Abou-Alfa, Chia-Jui Yen, Chih-Hung Hsu, et al.
JCO Precision Oncology|October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate CancerDavid R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Cancer Cell|November 1, 2019
Paradigms for Precision Medicine in Epichaperome Cancer TherapyNagavarakishore Pillarsetty, Komal Jhaveri, Tony Taldone, et al.
Hepatology (Baltimore, Md.)|February 15, 2012
Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantationDeborah L Diamond, Alexei L Krasnoselsky, Kristin E Burnum, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2018
Reproducibility and Repeatability of Semiquantitative <sup>18</sup>F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter StudyHebert Alberto Vargas, Gem M Kramer, Andrew M Scott, et al.
Pageof 136